Search research articles
Contact Us
Filters
Showing results (161-170 of 332) with videos related to
Page
of 34
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 25, 2024
Impact of the pre-biologic treatment journey on biologic drug survival in psoriasis: A nationwide cohort study
David Thein, Mia-Louise Nielsen, Julia-Tatjana Maul, et al.
Journal of the American Academy of Dermatology
|
October 9, 2021
The risk of COVID-19 infection in patients with atopic dermatitis: A retrospective cohort study
Jashin J Wu, Amylee Martin, Jeffrey Liu, et al.
Journal of the American Academy of Dermatology
|
March 18, 2018
Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3
Alexander Egeberg, Jashin J Wu, Neil Korman, et al.
Angewandte Chemie (International Ed. in English)
|
January 8, 2019
Samarium Polyarsenides Derived from Nanoscale Arsenic
Christoph Schoo, Sebastian Bestgen, Alexander Egeberg, et al.
Arthritis Research & Therapy
|
September 15, 2023
Nail psoriasis dynamics during biologic treatment and withdrawal in patients with psoriasis who may be at high risk of developing psoriatic arthritis: a post hoc analysis of the VOYAGE 2 randomized trial
William Tillett, Alexander Egeberg, Enikö Sonkoly, et al.
JAAD International
|
June 8, 2026
Epidemiology of lichen sclerosus in women: Findings from the Danish skin cohort
Jeanette Halskou Haugaard, Lea Nymand, Yuki Mf Andersen, et al.
Journal of the American Academy of Dermatology
|
June 12, 2017
Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis
Jacob P Thyssen, Peter B Toft, Anne-Sofie Halling-Overgaard, et al.
Journal of the American Academy of Dermatology
|
January 29, 2019
Real-world drug survival of ixekizumab for psoriasis
Erica B Lee, Deeti J Pithadia, Kelly A Reynolds, et al.
The Journal of Allergy and Clinical Immunology
|
October 25, 2016
Adult atopic dermatitis and the risk of type 2 diabetes
Yuki M F Andersen, Alexander Egeberg, Gunnar H Gislason, et al.
Clinical and Experimental Dermatology
|
June 7, 2022
Real-world dose adjustments of biologic treatments in psoriasis and their economic impact: a Swedish national population study
Alexander Egeberg, Jonatan Freilich, M Natalia Stelmaszuk, et al.
Page
of 34
Search research articles
Search
Showing results (161-170 of 332) with videos related to
Sort By:
Page
of 34
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 25, 2024
Impact of the pre-biologic treatment journey on biologic drug survival in psoriasis: A nationwide cohort study
David Thein, Mia-Louise Nielsen, Julia-Tatjana Maul, et al.
Journal of the American Academy of Dermatology
|
October 9, 2021
The risk of COVID-19 infection in patients with atopic dermatitis: A retrospective cohort study
Jashin J Wu, Amylee Martin, Jeffrey Liu, et al.
Journal of the American Academy of Dermatology
|
March 18, 2018
Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3
Alexander Egeberg, Jashin J Wu, Neil Korman, et al.
Angewandte Chemie (International Ed. in English)
|
January 8, 2019
Samarium Polyarsenides Derived from Nanoscale Arsenic
Christoph Schoo, Sebastian Bestgen, Alexander Egeberg, et al.
Arthritis Research & Therapy
|
September 15, 2023
Nail psoriasis dynamics during biologic treatment and withdrawal in patients with psoriasis who may be at high risk of developing psoriatic arthritis: a post hoc analysis of the VOYAGE 2 randomized trial
William Tillett, Alexander Egeberg, Enikö Sonkoly, et al.
JAAD International
|
June 8, 2026
Epidemiology of lichen sclerosus in women: Findings from the Danish skin cohort
Jeanette Halskou Haugaard, Lea Nymand, Yuki Mf Andersen, et al.
Journal of the American Academy of Dermatology
|
June 12, 2017
Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis
Jacob P Thyssen, Peter B Toft, Anne-Sofie Halling-Overgaard, et al.
Journal of the American Academy of Dermatology
|
January 29, 2019
Real-world drug survival of ixekizumab for psoriasis
Erica B Lee, Deeti J Pithadia, Kelly A Reynolds, et al.
The Journal of Allergy and Clinical Immunology
|
October 25, 2016
Adult atopic dermatitis and the risk of type 2 diabetes
Yuki M F Andersen, Alexander Egeberg, Gunnar H Gislason, et al.
Clinical and Experimental Dermatology
|
June 7, 2022
Real-world dose adjustments of biologic treatments in psoriasis and their economic impact: a Swedish national population study
Alexander Egeberg, Jonatan Freilich, M Natalia Stelmaszuk, et al.
Page
of 34